It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
COVID-19 Rapid Evidence Reviews
Toggle navigation
New Search
SK Repository
About
Help
Your Cart:
0
items
Refine Search
Refine Search
Revise search
Search
Document Type
Apply
Evidence Search Report
7
Rapid Review
Table
2
Research Team
Apply
Critical Care
2
EOC
1
Epidemiology & Modelling
1
Laboratory
4
Status
Apply
5. Updated review
3
3. Completed
5
Category
Apply
Administration
1
Clinical Management
4
Clinical Presentation
Diagnostics
1
Epidemiology
2
Healthcare Services
3
Infection Prevention and Control
1
Subject
Apply
Antibodies
2
Asymptomatic
1
Cancer
1
Chemotherapy
1
Clinical Presentation
3
Comorbidities
Critical Care
Health Planning
2
Immunity
3
Infection Prevention and Control
2
Long Covid
3
Mortality
1
More
Population
Apply
All
All adults
1
Clinical Setting
Apply
ICU
2
Advanced Search
All Records
All
Other
Clinical Presentation
Comorbidities
Natural History
Critical Care
Rapid Review
Sorted by
Research Question / Title
Sort by Relevance
Sort by Newest
Sort by Oldest
Table View
List View
Citation View
Expand all
Collapse all
Select All
8 records – page 1 of 1.
Prev
Next
Date
Research Question / Title
Unique ID
Research Team
April 15, 2020
At what time in the disease timeline of COVID-19 do antibodies develop?
LAB041402 RR
Laboratory
April 11, 2020
Is the IgM or IgG immune response protective?
LAB040803 RR
Laboratory
January 22, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2 RR
EOC
December 9, 2020
What are the predictors of mortality in hospitalized COVID-19 patients?
CC120402 RR
Critical Care
May 19, 2020
What are the risk factors for severity and death associated with COVID-19?
EPM050901 RR
Epidemiology & Modelling
February 27, 2021
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
CC011101 RR
Critical Care
May 19, 2020
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
LAB041601v2 RR
Laboratory
May 8, 2020
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
LAB040701v2 RR
Laboratory
8 records – page 1 of 1.
Prev
Next